UK markets closed
  • FTSE 100

    7,204.55
    +14.25 (+0.20%)
     
  • FTSE 250

    22,931.66
    +14.61 (+0.06%)
     
  • AIM

    1,234.19
    -7.18 (-0.58%)
     
  • GBP/EUR

    1.1812
    -0.0049 (-0.41%)
     
  • GBP/USD

    1.3760
    -0.0036 (-0.26%)
     
  • BTC-GBP

    44,211.94
    -2,175.88 (-4.69%)
     
  • CMC Crypto 200

    1,453.34
    -49.69 (-3.31%)
     
  • S&P 500

    4,544.90
    -4.88 (-0.11%)
     
  • DOW

    35,677.02
    +73.94 (+0.21%)
     
  • CRUDE OIL

    83.98
    +1.48 (+1.79%)
     
  • GOLD FUTURES

    1,793.10
    +11.20 (+0.63%)
     
  • NIKKEI 225

    28,804.85
    +96.27 (+0.34%)
     
  • HANG SENG

    26,126.93
    +109.40 (+0.42%)
     
  • DAX

    15,542.98
    +70.42 (+0.46%)
     
  • CAC 40

    6,733.69
    +47.52 (+0.71%)
     

Dr. Edgar Diaz, Respected Veterinarian and Technical Expert, Joins Swine Team

·2-min read

Ceva Swine names Dr. Edgar Diaz Swine Technical Services Manager

LENEXA, Kan., September 24, 2021--(BUSINESS WIRE)--Edgar Diaz, an accomplished scientist, academic, veterinarian and business leader in animal health, has joined Ceva Animal Health as Swine Technical Services Manager. In his new role, Dr. Diaz will focus on continuing to grow the company’s customized swine vaccines, developing the genomics platform and supporting the sales team in providing tailor-made solutions to swine veterinarians and producers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210924005512/en/

Dr. Edgar Diaz, respected veterinarian and technical expert, joins Ceva Animal Health as Swine Technical Services Manager. (Photo: Business Wire)

"We are very proud to welcome Dr. Diaz to the team," said Gary Robertson, director, swine business unit. "As a highly respected veterinarian, dedicated leader and proven executive, Dr. Diaz has a unique combination of skills and perspectives. With more than 30 years of experience in swine medicine, his knowledge augments our extensive expertise in swine disease management. His comprehensive background in research and as a practitioner will provide incredibly valuable insights as we continue our growth and leadership in animal health."

Dr. Diaz most recently served as the Director of Marketing at Newport Laboratories for Boehringer Ingelheim Animal Health, and he also served as President of Newport Laboratories from 2017 to 2019. He has also served as a business manager and held several technical services positions over the course of his career in the United States, Spain and Mexico.

Dr. Diaz received his Doctor of Veterinary Medicine and Zootecnia from the National Autonomous University of Mexico in 1989, where he also taught pathology, clinical swine diagnostics and immunology. He has authored more than 200 technical papers, articles and research bulletins on a wide variety of global swine diseases and health issues.

"Ceva has an excellent reputation for innovation and customer care in the animal health industry, and I’m honored to be a part of it," Dr. Diaz said. "I look forward to working closely with Gary and the sales team to amplify the impact of our company’s remarkable capabilities for veterinarians and producers."

For more information about Ceva Swine or for career opportunities, visit www.ceva.us

About Ceva Animal Health:

Ceva Animal Health offers a growing line of products to meet the health needs of companion animals, poultry, and swine. Ceva established its U.S. presence in 2005. Since then, the company has invested nearly $100 million in facilities supporting the growth in research and development plus vaccine production. Ceva currently supplies more than 70 countries with critical vaccines from the company’s North American headquarters located in Lenexa, Kansas. To learn more visit www.ceva.us.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210924005512/en/

Contacts

Jody Donohue, APR, SCMP
Communications Manager
Ceva Animal Health
Office: (913) 945-4405
Mobile: (913) 333-6329
Email: jody.donohue@ceva.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting